Insider Selling: Intuitive Surgical, Inc. (ISRG) VP Sells $123,002.22 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Jamie Samath sold 227 shares of Intuitive Surgical stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $541.86, for a total transaction of $123,002.22. Following the completion of the sale, the vice president now directly owns 138 shares of the company’s stock, valued at approximately $74,776.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Jamie Samath also recently made the following trade(s):

  • On Tuesday, October 23rd, Jamie Samath sold 864 shares of Intuitive Surgical stock. The shares were sold at an average price of $499.21, for a total transaction of $431,317.44.

Shares of ISRG opened at $519.09 on Friday. The stock has a market cap of $59.25 billion, a PE ratio of 72.20, a P/E/G ratio of 3.75 and a beta of 1.03. Intuitive Surgical, Inc. has a 52 week low of $359.75 and a 52 week high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, beating the Zacks’ consensus estimate of $2.66 by $0.17. The business had revenue of $920.90 million during the quarter, compared to analyst estimates of $916.22 million. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.77 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.52 EPS for the current fiscal year.

A number of research analysts have weighed in on ISRG shares. Wells Fargo & Co boosted their target price on shares of Intuitive Surgical from $575.00 to $635.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 12th. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 target price for the company in a research report on Tuesday, October 9th. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 22nd. Raymond James upped their price objective on shares of Intuitive Surgical from $620.00 to $630.00 and gave the company an “outperform” rating in a research report on Friday, October 19th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $560.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 19th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and sixteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $556.01.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Intuitive Surgical by 0.4% in the third quarter. Vanguard Group Inc. now owns 8,313,421 shares of the medical equipment provider’s stock valued at $4,771,903,000 after acquiring an additional 29,260 shares during the period. BlackRock Inc. increased its stake in Intuitive Surgical by 2.0% in the third quarter. BlackRock Inc. now owns 7,758,427 shares of the medical equipment provider’s stock valued at $4,453,337,000 after acquiring an additional 149,491 shares during the period. FMR LLC increased its stake in Intuitive Surgical by 19.2% in the second quarter. FMR LLC now owns 6,629,648 shares of the medical equipment provider’s stock valued at $3,172,155,000 after acquiring an additional 1,068,107 shares during the period. Capital World Investors increased its stake in Intuitive Surgical by 6.8% in the third quarter. Capital World Investors now owns 2,942,531 shares of the medical equipment provider’s stock valued at $1,689,013,000 after acquiring an additional 188,476 shares during the period. Finally, Morgan Stanley increased its stake in Intuitive Surgical by 119.5% in the third quarter. Morgan Stanley now owns 2,856,195 shares of the medical equipment provider’s stock valued at $1,639,456,000 after acquiring an additional 1,554,896 shares during the period. 84.31% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2018/12/07/insider-selling-intuitive-surgical-inc-isrg-vp-sells-123002-22-in-stock.html.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Recommended Story: What does RSI mean?

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply